Switch to:

Adaptive Biotechnologies EV-to-EBITDA

: -53.94 (As of Today)
View and export this data going back to 2019. Start your Free Trial

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Adaptive Biotechnologies's enterprise value is $5,698.78 Mil. Adaptive Biotechnologies's EBITDA for the trailing twelve months (TTM) ended in Jun. 2020 was $-105.66 Mil. Therefore, Adaptive Biotechnologies's EV-to-EBITDA for today is -53.94.

NAS:ADPT' s EV-to-EBITDA Range Over the Past 10 Years
Min: -80.2   Med: -44.3   Max: -1.4
Current: -53.93

-80.2
-1.4

During the past 3 years, the highest EV-to-EBITDA of Adaptive Biotechnologies was -1.40. The lowest was -80.20. And the median was -44.30.

NAS:ADPT's EV-to-EBITDA is ranked lower than
99.99% of the 275 Companies
in the Biotechnology industry.

( Industry Median: 29.32 vs. NAS:ADPT: -53.93 )

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2020-09-18), Adaptive Biotechnologies's stock price is $45.31. Adaptive Biotechnologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2020 was $-0.79. Therefore, Adaptive Biotechnologies's PE Ratio for today is .

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Adaptive Biotechnologies EV-to-EBITDA Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Adaptive Biotechnologies Annual Data
Dec17 Dec18 Dec19
EV-to-EBITDA 0.00 0.00 -45.42

Adaptive Biotechnologies Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
EV-to-EBITDA Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -104.82 -53.92 -45.42 -35.12 0.00

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Adaptive Biotechnologies EV-to-EBITDA Distribution

* The bar in red indicates where Adaptive Biotechnologies's EV-to-EBITDA falls into.



Adaptive Biotechnologies EV-to-EBITDA Calculation

Adaptive Biotechnologies's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=5698.782/-105.656
=-53.94

Adaptive Biotechnologies's current Enterprise Value is $5,698.78 Mil.
Adaptive Biotechnologies's EBITDA for the trailing twelve months (TTM) ended in Jun. 2020 was -15.99 (Sep. 2019 ) + -22.113 (Dec. 2019 ) + -32.642 (Mar. 2020 ) + -34.911 (Jun. 2020 ) = $-105.66 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Adaptive Biotechnologies  (NAS:ADPT) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Adaptive Biotechnologies's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=45.31/-0.79
=

Adaptive Biotechnologies's share price for today is $45.31.
Adaptive Biotechnologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2020 was -0.11 (Sep. 2019 ) + -0.17 (Dec. 2019 ) + -0.25 (Mar. 2020 ) + -0.26 (Jun. 2020 ) = $-0.79.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Adaptive Biotechnologies EV-to-EBITDA Related Terms


Adaptive Biotechnologies EV-to-EBITDA Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)